Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification von Betof, A S, Rabbani, Z N, Hardee, M E, Kim, S J, Broadwater, G, Bentley, R C, Snyder, S A, Vujaskovic, Z, Oosterwijk, E, Harris, L N, Horton, J K, Dewhirst, M W, Blackwell, K L

Volltext

Leadership lessons for any occasion: stories of our mothers von Betof, Ed, Betof, Nila

Volltext

Just promoted!: a 12-month road map for success in your new leadership role von Betof, H, Betof, Nila

Volltext

Leaders as teachers: unlock the teaching potential of your company's best and brightest von Betof, Edward

Volltext

The future of cancer immunotherapy: microenvironment-targeting combinations von Murciano-Goroff, Yonina R., Warner, Allison Betof, Wolchok, Jedd D.

Volltext

Tumor-Infiltrating Lymphocyte Therapy in Melanoma: Facts to the Future von Betof Warner, Allison, Corrie, Pippa G, Hamid, Omid

Volltext

Modulation of murine breast tumor vascularity, hypoxia and chemotherapeutic response by exercise von Betof, Allison S, Lascola, Christopher D, Weitzel, Douglas, Landon, Chelsea, Scarbrough, Peter M, Devi, Gayathri R, Palmer, Gregory, Jones, Lee W, Dewhirst, Mark W

Volltext

Exercise as an Immune Boost: Mechanism-Driven Support for Lifestyle Interventions von Betof Warner, Allison

Volltext

Long-Term Outcomes and Responses to Retreatment in Patients With Melanoma Treated With PD-1 Blockade von Betof Warner, Allison, Palmer, Jessica S, Shoushtari, Alexander N, Goldman, Debra A, Panageas, Katherine S, Hayes, Sara A, Bajwa, Raazi, Momtaz, Parisa, Callahan, Margaret K, Wolchok, Jedd D, Postow, Michael A, Chapman, Paul B

Volltext

CD4+ TIL to the Rescue of Anti-PD-1 Failure by Targeting MHC-II von Betof Warner, Allison, Luke, Jason J

Volltext

Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma von Pollack, M.H., Betof, A., Dearden, H., Rapazzo, K., Valentine, I., Brohl, A.S., Ancell, K.K., Long, G.V., Menzies, A.M., Eroglu, Z., Johnson, D.B., Shoushtari, A.N.

Volltext

Efficacy and Mechanisms of Aerobic Exercise on Cancer Initiation, Progression, and Metastasis: A Critical Systematic Review of In Vivo Preclinical Data von Ashcraft, Kathleen A, Peace, Ralph M, Betof, Allison S, Dewhirst, Mark W, Jones, Lee W

Volltext

578 von Warner, Allison Betof

Volltext

Effects and potential mechanisms of exercise training on cancer progression: A translational perspective von Betof, Allison S, Dewhirst, Mark W, Jones, Lee W

Volltext

T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants von Hirschhorn, Daniel, Budhu, Sadna, Kraehenbuehl, Lukas, Gigoux, Mathieu, Schröder, David, Chow, Andrew, Ricca, Jacob M., Gasmi, Billel, De Henau, Olivier, Mangarin, Levi Mark B., Li, Yanyun, Hamadene, Linda, Flamar, Anne-Laure, Choi, Hyejin, Cortez, Czrina A., Liu, Cailian, Holland, Aliya, Schad, Sara, Schulze, Isabell, Betof Warner, Allison, Hollmann, Travis J., Arora, Arshi, Panageas, Katherine S., Rizzuto, Gabrielle A., Duhen, Rebekka, Weinberg, Andrew D., Spencer, Christine N., Ng, David, He, Xue-Yan, Albrengues, Jean, Redmond, David, Egeblad, Mikala, Wolchok, Jedd D., Merghoub, Taha

Volltext

Can Exercise-Induced Modulation of the Tumor Physiologic Microenvironment Improve Antitumor Immunity? von Zhang, Xiaojie, Ashcraft, Kathleen A, Betof Warner, Allison, Nair, Smita K, Dewhirst, Mark W

Volltext

Impact of Age on Outcomes with Immunotherapy for Patients with Melanoma von Betof, Allison S., Nipp, Ryan D., Giobbie‐Hurder, Anita, Johnpulle, Romany A. N., Rubin, Krista, Rubinstein, Samuel M., Flaherty, Keith T., Lawrence, Donald P., Johnson, Douglas B., Sullivan, Ryan J.

Volltext

Randomized Phase II Trial of Proton Craniospinal Irradiation Versus Photon Involved-Field Radiotherapy for Patients With Solid Tumor Leptomeningeal Metastasis von Yang, Jonathan T, Wijetunga, N Ari, Pentsova, Elena, Wolden, Suzanne, Young, Robert J, Correa, Denise, Zhang, Zhigang, Zheng, Junting, Steckler, Alexa, Bucwinska, Weronika, Bernstein, Ashley, Betof Warner, Allison, Yu, Helena, Kris, Mark G, Seidman, Andrew D, Wilcox, Jessica A, Malani, Rachna, Lin, Andrew, DeAngelis, Lisa M, Lee, Nancy Y, Powell, Simon N, Boire, Adrienne

Volltext

Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort study von Pires da Silva, Ines, Ahmed, Tasnia, Reijers, Irene L M, Weppler, Alison M, Betof Warner, Allison, Patrinely, James Randall, Serra-Bellver, Patricio, Allayous, Clara, Mangana, Joanna, Nguyen, Khang, Zimmer, Lisa, Trojaniello, Claudia, Stout, Dan, Lyle, Megan, Klein, Oliver, Gerard, Camille L, Michielin, Olivier, Haydon, Andrew, Ascierto, Paolo A, Carlino, Matteo S, Lebbe, Celeste, Lorigan, Paul, Johnson, Douglas B, Sandhu, Shahneen, Lo, Serigne N, Blank, Christian U, Menzies, Alexander M, Long, Georgina V

Volltext

Early Use of High-Dose Glucocorticoid for the Management of irAE Is Associated with Poorer Survival in Patients with Advanced Melanoma Treated with Anti-PD-1 Monotherapy von Bai, Xue, Hu, Jiani, Betof Warner, Allison, Quach, Henry T, Cann, Christopher G, Zhang, Michael Z, Si, Lu, Tang, Bixia, Cui, Chuanliang, Yang, Xiaoling, Wei, Xiaoting, Pallan, Lalit, Harvey, Catriona, Manos, Michael P, Ouyang, Olivia, Kim, Michelle S, Kasumova, Gyulnara, Cohen, Justine V, Lawrence, Donald P, Freedman, Christine, Fadden, Riley M, Rubin, Krista M, Sharova, Tatyana, Frederick, Dennie T, Flaherty, Keith T, Rahma, Osama E, Long, Georgina V, Menzies, Alexander M, Guo, Jun, Shoushtari, Alexander N, Johnson, Douglas B, Sullivan, Ryan J, Boland, Genevieve M

Volltext